| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The effects of continuous or acute administration of insulin or insulin-like growth factor-I (IGF-I) on IGF-I mRNA and IGF-I receptor mRNA were studied in the skeletal muscle (gastrocnemius), heart muscle and vascular smooth muscle (aorta) of non-diabetic and diabetic rats using a solution hybridization assay. The levels of IGF-I mRNA in the different types of muscle markedly decreased by diabetes, whereas changes in IGF-I receptor mRNA were less consistent. Continuous infusion of diabetic rats with insulin (28 or 35 nmol/day) for 4 days normalized the altered levels of IGF-I mRNA and IGF-1 receptor mRNA. Infusion of equimolar concentrations of IGF-I did not affect IGF-I mRNA, but decreased the level of IGF-I receptor mRNA in skeletal muscle.
In acute experiments, rats were injected with equipotent blood glucose-lowering doses of insulin (14 nmol) or IGF-I (107 nmol). Insulin did not significantly affect levels of IGF-I mRNA, but decreased levels of IGF-I receptor mRNA in skeletal muscle and aorta. IGF-I increased levels of IGF-I mRNA in heart muscle, and markedly decreased levels of IGF-I receptor mRNA in skeletal muscle and heart muscle from non-diabetic and diabetic rats.
In conclusion, exogenous IGF-I and insulin can increase IGF-I mRNA and decrease IGF-I receptor mRNA, indicating that both insulin and IGF-I can act as regulators of the IGF-I system in muscle in vivo.
Journal of Endocrinology (1992) 135, 203–211
This article has been cited by other articles:
|
|
 |
|
  G. S. Johansson and H. J. Arnqvist Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1124 - E1130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nigro, N. Osman, A. M. Dart, and P. J. Little Insulin Resistance and Atherosclerosis Endocr. Rev., May 1, 2006; 27(3): 242 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Liu, W. Long, D. A. Fryburg, and E. J. Barrett The Regulation of Body and Skeletal Muscle Protein Metabolism by Hormones and Amino Acids J. Nutr., January 1, 2006; 136(1): 212S - 217S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Delafontaine, Y.-H. Song, and Y. Li Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 435 - 444. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Ren, J. Duan, K. K Hintz, and B. H Ren High glucose induces cardiac insulin-like growth factor I resistance in ventricular myocytes: role of Akt and ERK activation Cardiovasc Res, March 1, 2003; 57(3): 738 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Duan, H.-Y. Zhang, S. D. Adkins, B. H. Ren, F. L. Norby, X. Zhang, J. N. Benoit, P. N. Epstein, and J. Ren Impaired cardiac function and IGF-I response in myocytes from calmodulin-diabetic mice: role of Akt and RhoA Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E366 - E376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. L. Norby, L. E. Wold, J. Duan, K. K. Hintz, and J. Ren IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E658 - E666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Kassab, S. McFarlane, and J. Sowers Vascular complications in diabetes and their prevention Vascular Medicine, November 1, 2001; 6(4): 249 - 255. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Nishiyama, D. N. Ishii, P. H. Backx, B. E. Pulford, B. R. Birks, and M. M. Tamkun Altered K+ channel gene expression in diabetic rat ventricle: isoform switching between Kv4.2 and Kv1.4 Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1800 - H1807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cianfarani, R. Bonfanti, M. L. M. Bitti, D. Germani, S. Boemi, G. Chiumello, and B. Boscherini Growth and Insulin-Like Growth Factors (IGFs) in Children with Insulin-Dependent Diabetes Mellitus at the Onset of Disease: Evidence for Normal Growth, Age Dependency of the IGF System Alterations, and Presence of a Small (Approximately 18-Kilodalton) IGF-Binding Protein-3 Fragment in Serum J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4162 - 4167. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Q. Galvan, F. Galetta, A. Natali, E. Muscelli, A. M. Sironi, G. Cini, S. Camastra, and E. Ferrannini Insulin Resistance and Hyperinsulinemia : No Independent Relation to Left Ventricular Mass in Humans Circulation, October 31, 2000; 102(18): 2233 - 2238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ren Attenuated cardiac contractile responsiveness to insulin-like growth factor I in ventricular myocytes from biobreeding spontaneous diabetic rats Cardiovasc Res, April 1, 2000; 46(1): 162 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ren, M. F. Walsh, M. Hamaty, J. R. Sowers, and R. A. Brown Altered inotropic response to IGF-I in diabetic rat heart: influence of intracellular Ca2+ and NO Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H823 - H830. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
